Differences in methylation profiles between long-term survivors and short-term survivors of IDH- wildtype glioblastoma

Abstract Background Patients with glioblastoma (GBM) have a median overall survival (OS) of approximately 16 months. However, approximately 5% of patients survive >5 years. This study examines the differences in methylation profiles between long-term survivors (>5 years, LTS) a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthijs van der Meulen, Ronald Ramos, Mathew Voisin, Vikas Patil, Qingxia Wei, Olivia Singh, Seth Climans, Navya Kalidindi, Rosemarylin Or, Ken Aldape, Phedias Diamandis, David G. Muñoz, Gelareh Zadeh, Warren Mason
Formato: Artigo
Lenguaje:inglés
Publicado: 2024
Acceso en línea:https://doi.org/10.1093/noajnl/vdae001
https://academic.oup.com/noa/advance-article-pdf/doi/10.1093/noajnl/vdae001/55536889/vdae001.pdf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!